跳至主要内容
临床试验/JPRN-UMIN000001587
JPRN-UMIN000001587未知未知

Therapeutic efficacy of olmesartan, telmisartan and amlodipine to compare with histologic improvement and addciation about AGTR1 gene polymorphisms in subjects with nonalcoholic steatohepatitis (NASH); randomized open-labeled prospective study. - Therapeutic efficacy of olmesartan, telmisartan and amlodipine in subjects with nonalcoholic steatohepatitis (NASH)

Yokohama City University Hospital0 个研究点目标入组 60 人开始时间: 2008年12月25日最近更新:
适应症

试验速览

阶段
未知
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)The patient with diabetes mellitus(HbA1c>6.2) 2) contraction of renal artery. 3) The criteria for exclusion from participation in the study: history of hepatic disease, such as chronic hepatitis C or concurrent active hepatitis B (serum positive for hepatitis B surface antigen), autoimmune hepatitis, primary biliary cirrhosis (PBC), sclerosing cholangitis, hemochromatosis, wilsons disease, and current or past consumption of more than 20g of alcohol daily. 4) an anamnesis of drug allergy to use.

研究者

相似试验